Canada-based venture capital and private equity investment firm Polar Capital has appointed Deane Donnigan and David Pinniger for its healthcare team, as the company eyes a massive expansion strategy for its healthcare investment products in the near term.
Donnigan was formerly associated with Axa Framlington as fund manager, while David Pinniger was serving as trust manager with International Biotechnology.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
A clinical pharmacist by profession, Donnigan had been associated with Framlington’s healthcare unit trust arm between 1997 and 2011. During the period she was escalated to the position of manager for Axa Framlington Healthcare and Biotechnology funds.
With over 12 years experience in the healthcare sector, Pinniger had been associated with International Biotechnology trust of SV Life Sciences for the past five years. Pinniger in his career has also worked with Abingworth and Morgan Stanley as an analyst.
Daniel Mahony, fund manager with Polar Healthcare, said: "The healthcare sector remains one of the most exciting markets from an investment perspective and we are pleased to grow the team as we look to expand the healthcare franchise.
"We can now offer our clients a broader range of specialist products that target the significant opportunities we see in the healthcare sector."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
